Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The development of an effective HIV-1 vaccine remains a global priority. Neutralizing antibodies (nAbs), which block infection by cell-free virus, are likely to be an important response for vaccines to elicit. However, evidence from the RV144 vaccine trial and non-human primate vaccine studies sugge...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Virology
2018
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|